State Treasurer State of Michigan grew its position in Molina Healthcare (NYSE:MOH) by 6.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 16,800 shares of the company’s stock after buying an additional 1,000 shares during the period. State Treasurer State of Michigan’s holdings in Molina Healthcare were worth $1,364,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of the business. Renaissance Technologies LLC grew its stake in shares of Molina Healthcare by 53.5% in the fourth quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock worth $165,334,000 after acquiring an additional 751,800 shares during the period. Victory Capital Management Inc. grew its stake in shares of Molina Healthcare by 17.1% in the first quarter. Victory Capital Management Inc. now owns 1,862,307 shares of the company’s stock worth $151,182,000 after acquiring an additional 271,898 shares during the period. Iridian Asset Management LLC CT bought a new stake in shares of Molina Healthcare in the fourth quarter worth approximately $128,179,000. Southpoint Capital Advisors LP bought a new stake in shares of Molina Healthcare in the fourth quarter worth approximately $60,577,000. Finally, Teachers Advisors LLC grew its stake in shares of Molina Healthcare by 39.7% in the fourth quarter. Teachers Advisors LLC now owns 650,188 shares of the company’s stock worth $49,856,000 after acquiring an additional 184,674 shares during the period.
Shares of Molina Healthcare opened at $87.60 on Friday, according to Marketbeat Ratings. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.36 and a quick ratio of 1.36. The company has a market cap of $5.37 billion, a P/E ratio of 156.43, a price-to-earnings-growth ratio of 1.38 and a beta of 1.20. Molina Healthcare has a 12-month low of $56.67 and a 12-month high of $93.98.
Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Monday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.90. Molina Healthcare had a negative net margin of 2.46% and a positive return on equity of 20.08%. The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.74 billion. During the same quarter in the previous year, the firm earned $0.63 earnings per share. The company’s revenue for the quarter was down 5.3% on a year-over-year basis. equities research analysts anticipate that Molina Healthcare will post 4.63 EPS for the current year.
In other Molina Healthcare news, Director Steven J. Orlando sold 1,500 shares of the business’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $72.77, for a total transaction of $109,155.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director John C. Molina sold 62,420 shares of the business’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $72.13, for a total transaction of $4,502,354.60. Following the transaction, the director now owns 393,410 shares in the company, valued at approximately $28,376,663.30. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 87,061 shares of company stock worth $6,305,956. 0.65% of the stock is owned by insiders.
A number of analysts have recently commented on the stock. Morgan Stanley lifted their price target on shares of Molina Healthcare from $91.00 to $100.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 1st. ValuEngine upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, March 2nd. BMO Capital Markets reduced their price target on shares of Molina Healthcare from $98.00 to $85.00 and set a “market perform” rating for the company in a research note on Wednesday, February 14th. Jefferies Group reiterated a “hold” rating and issued a $80.00 price target on shares of Molina Healthcare in a research note on Wednesday, February 14th. Finally, Zacks Investment Research upgraded shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $96.00 price target for the company in a research note on Tuesday, April 17th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $80.92.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare (NYSE:MOH).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.